Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.9% in Advanced Drainage Systems, Inc. common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a 7.8% beneficial ownership stake in Agios Pharmaceuticals Inc., totaling 4,513,170 common shares.

BlackRock, Inc. has reported a 5.2% beneficial ownership stake in Alkami Technology, Inc. common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a continued 9.9% passive beneficial ownership stake in ATI Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.3% of Ally Financial Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.4% of Altice USA, Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, revealing a 5.1% beneficial ownership stake in American Battery Technology Co, totaling 4,708,374 common shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 13.4% beneficial ownership of common stock in American Eagle Outfitters Inc. as of June 30, 2025.

BlackRock, Inc. has reported a passive beneficial ownership of 5.1% of the common stock of American Outdoor Brands Inc., totaling 652,776 shares.

BlackRock, Inc. has reported a passive beneficial ownership of 5.5% of Amylyx Pharmaceuticals, Inc.'s common stock, totaling 4,917,501 shares.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 15.0% of Apollo Commercial Real Estate Finance, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 8.6% of Applied Industrial Technologies Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 15.2% in Armada Hoffler Properties Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, reporting a beneficial ownership of 9.0% of Array Technologies Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has disclosed an increased beneficial ownership of 14.4% in B&G Foods Inc., holding over 11.5 million shares as a passive investment.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.8% beneficial ownership stake in BANKFINANCIAL CORP's common stock.

BlackRock, Inc. has filed a Schedule 13G, reporting a 6.8% beneficial ownership stake in BigBear.ai Holdings, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an updated Schedule 13G, revealing a 12.6% beneficial ownership in BlackLine, Inc.'s common stock, held for passive investment purposes.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Kestrel Group Ltd's Common Stock as of June 30, 2025.

BlackRock, Inc. has reported a 5.9% beneficial ownership stake in Restaurant Brands International Inc., holding over 19.2 million common shares as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.2% of Amrize Ltd's common stock as of June 30, 2025.

BlackRock, Inc. has reported a 5.6% beneficial ownership stake in ATOMERA INC, holding 1,720,244 shares of common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a 7.1% beneficial ownership stake in TrueBlue Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 1.8% beneficial ownership stake in TScan Therapeutics, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.0% in Virtra Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 2.2% passive beneficial ownership stake in Zentalis Pharmaceuticals Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.8% in Zymeworks Inc.'s common stock.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a passive beneficial ownership of 3.3% of Aurora Innovation Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. files Schedule 13G, reporting beneficial ownership of 7.8% of Bloom Energy Corporation's Class A stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a passive beneficial ownership of 4.98% of CBL AND ASSOCIATES PROPERTIES INC common stock as of June 30, 2025.